sales@contrivedatuminsights.com
CDI - Contrive Datum Insights
Pharmaceuticals & Biotech

Digital Biology MarketSize, Share & Industry Analysis, 2026-2034By ComponentBy ApplicationBy TechnologyBy End UserBy Deployment ModeBy Biological Data TypeBy Therapeutic AreaBy Therapeutic ModalityBy Business Model

Full title & scope — all 9 axes with their segments

Digital Biology Market Size, Share & Industry Analysis, By Component (Software and Platforms, Services, Hardware and Instruments, Data and Content), By Application (Drug Discovery, Synthetic Biology, Precision Medicine, Clinical Diagnostics, Agricultural Biotechnology, Industrial Biotechnology), By Technology (Artificial Intelligence and Machine Learning, Computational Biology and Bioinformatics, Multi-Omics Analytics, Digital Twins and Biosimulation, Lab Automation and Robotics, Cloud and High-Performance Computing), By End User (Pharmaceutical Companies, Biotechnology Companies, Academic and Research Institutes, Healthcare Providers, Contract Research Organizations, Agricultural Companies), By Deployment Mode (Cloud-Based, On-Premises, Hybrid), By Biological Data Type (Genomic Data, Proteomic Data, Transcriptomic Data, Metabolomic Data, Imaging and Phenotypic Data, Clinical and Real-World Data), By Therapeutic Area (Oncology, Neurology, Infectious Diseases, Immunology and Inflammation, Rare and Genetic Diseases, Metabolic and Cardiovascular Diseases), By Therapeutic Modality (Small Molecules, Biologics and Antibodies, Cell and Gene Therapies, Nucleic Acid Therapeutics, Vaccines), By Business Model (Software Licensing and Subscription, Platform-as-a-Service, Fee-for-Service and Contract Research, Collaboration and Milestone-Based, Data Licensing), and Regional Forecast, 2026-2034

Last Updated: Nov 3, 2026Format: PDFReport ID: CDI-248841
Segmentation

Segment definitions and share of revenue by product, animal, end user and region.

Segmented by
Component
Application
Technology
End User
Deployment Mode
Biological Data Type
Therapeutic Area
Therapeutic Modality
Business Model
Structure

Segmentation Analysis

9 axes

By Component

4
  • 01Software and Platforms
  • 02Services
  • 03Hardware and Instruments
  • 04Data and Content

By Application

6
  • 01Drug Discovery
  • 02Synthetic Biology
  • 03Precision Medicine
  • 04Clinical Diagnostics
  • 05Agricultural Biotechnology
  • 06Industrial Biotechnology

By Technology

6
  • 01Artificial Intelligence and Machine Learning
  • 02Computational Biology and Bioinformatics
  • 03Multi-Omics Analytics
  • 04Digital Twins and Biosimulation
  • 05Lab Automation and Robotics
  • 06Cloud and High-Performance Computing

By End User

6
  • 01Pharmaceutical Companies
  • 02Biotechnology Companies
  • 03Academic and Research Institutes
  • 04Healthcare Providers
  • 05Contract Research Organizations
  • 06Agricultural Companies

By Deployment Mode

3
  • 01Cloud-Based
  • 02On-Premises
  • 03Hybrid

By Biological Data Type

6
  • 01Genomic Data
  • 02Proteomic Data
  • 03Transcriptomic Data
  • 04Metabolomic Data
  • 05Imaging and Phenotypic Data
  • 06Clinical and Real-World Data

By Therapeutic Area

6
  • 01Oncology
  • 02Neurology
  • 03Infectious Diseases
  • 04Immunology and Inflammation
  • 05Rare and Genetic Diseases
  • 06Metabolic and Cardiovascular Diseases

By Therapeutic Modality

5
  • 01Small Molecules
  • 02Biologics and Antibodies
  • 03Cell and Gene Therapies
  • 04Nucleic Acid Therapeutics
  • 05Vaccines

By Business Model

5
  • 01Software Licensing and Subscription
  • 02Platform-as-a-Service
  • 03Fee-for-Service and Contract Research
  • 04Collaboration and Milestone-Based
  • 05Data Licensing

Segment categories shown for scope reference. See the Summary tab for revenue share by Component. Full segment-by-segment detail across every axis is available in the sample and full report.

Scope

Questions This Report Answers

6 questions
01

What is the market size and growth rate, globally and by region?

02

How is the market segmented, and which segments lead?

03

Which regions and countries are covered, and how do they compare?

04

What are the key drivers, restraints, opportunities and challenges?

05

Who are the leading companies operating in this market?

06

What trends are expected to shape the market through the forecast period?

Questions

Frequently Asked Questions

01What is the Digital Biology Market projected to reach?

USD 44.8 USD Billion by 2034, CAGR 15.65%

02What years does this report cover?

Study period 2020–2034, base year 2025, historical data 2020-2024, forecast period 2026-2034.

03Which regions are covered?

North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

04Which region accounted for the largest market share?

North America leads with 42% of global revenue through 2034.

05Which segment leads the market?

Software and Platforms is the largest line by component, at 38% of revenue in 2025.

06Who are the key companies profiled?

Thermo Fisher Scientific Inc., Illumina, Inc., Schrödinger, Inc., Certara, Inc., Dassault Systèmes SE, Insilico Medicine, Recursion Pharmaceuticals, Inc., Exscientia plc, Benchling, Inc., Agilent Technologies, Inc., QIAGEN N.V., Danaher Corporation, Revvity, Inc., Twist Bioscience Corporation, Ginkgo Bioworks Holdings, Inc., Simulations Plus, Inc., Absci Corporation, Evotec SE, Compugen Ltd., BenevolentAI, Genedata AG, Bio-Rad Laboratories, Inc., 10x Genomics, Inc., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies plc, NVIDIA Corporation, Tempus AI, Inc., Dotmatics, Cellarity, Inc.. Full profiles are part of the paid report.

07Can the segmentation be customized?

Yes. Custom data cuts by geography, segment, or competitor set are available on request.

425+
Dedicated research analysts
1,200+
Reports published
Why CDI

Why choose CDI

Data triangulated across primary and secondary sources
Complimentary analyst call included with every purchase
Custom data cuts and post-purchase support available

Need this report shaped around your question?

The scope isn't fixed. Tell us what your team needs that the standard edition doesn't cover, and an analyst will come back on what can be adjusted and how long it takes, before you commit to anything.

Most licences include 30–60 hours of customization at no extra cost. See what each licence includes

Request customization

Additional Companies

Add competitors, suppliers or the peer set you benchmark against to the companies already covered.

Deeper Competitive View

Sharpen the landscape work around your own position: product line, channel, or a named shortlist of rivals.

Extra Segment Splits

Break the market down along an axis the standard scope doesn't cut it by, or go a level deeper inside one.

Application Focus

Narrow the analysis to the specific use cases and end users your team actually sells into.

Different Time Frame

Move the base year, or widen the historical and forecast windows the study is built on.

Country-Level Detail

Go below region level into the individual countries that matter to you, rather than the standard geography split.